XTL Biopharmaceuticals Ltd.

XTLB

$2.26

-9.60%

N/A-$0.24

Healthcare

Biotechnology

NASDAQ

Active Trading

XTL Biopharmaceuticals Ltd. is a biopharmaceutical firm dedicated to identifying and advancing novel drug therapies for autoimmune conditions. Its primary investigational compound, ...

Historical Employee Count of XTLB

Current

Minimum

Maximum

Recent Filings

Report Date	Form Type	Filing Date	SEC Filing
Dec 31, 2025	20-F	Jun 30, 2026	View
Dec 31, 2024	20-F	Apr 30, 2025	View
Dec 31, 2023	20-F	Apr 30, 2024	View
Dec 31, 2022	20-F	Mar 22, 2023	View
Dec 31, 2021	20-F	Mar 30, 2022	View

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer